ClarifyingComplexities of ExpandingTreatmentOptionsFor AdvancedAndEarly-Stage HR+/HER2- BreastCancer PeerView Oncology 1:40:47 1 year ago 844 Скачать Далее
Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer Medscape 30:49 Streamed 1 year ago 751 Скачать Далее
Unmet needs and CDK4/6 inhibitors in HR+/HER2- early breast cancer VJOncology 2:06 1 year ago 251 Скачать Далее
Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 Inhibitors PeerView Oncology 1:09:24 2 years ago 2 040 Скачать Далее
Dr. Denduluri on Treatment Approaches in Early-Stage HR+/HER2- Breast Cancer OncLive 1:51 4 years ago 919 Скачать Далее
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal PeerView Oncology 51:40 1 year ago 2 016 Скачать Далее
Management of premenopausal HR+/HER2- breast cancer with micro-metastasis VJOncology 2:14 1 year ago 227 Скачать Далее
Key challenge associated with the management of HR+/HER2- breast cancer VJOncology 0:35 1 year ago 94 Скачать Далее
Camizestrant may be superior to fulvestrant in patients with HR-positive, HER2-negative BC ecancer 4:05 1 year ago 98 Скачать Далее
Optimizing treatment in patients with early-stage HER2-positive breast cancer VJOncology 4:12 1 year ago 5 979 Скачать Далее
Defining Optimal Therapy in High-Risk Early Breast Cancer #shorts Medscape 1:00 2 years ago 751 Скачать Далее
Ask the expert: Early-stage HER2-positive breast cancer with Adrienne Waks, MD Living Beyond Breast Cancer 1:05:11 1 year ago 11 264 Скачать Далее
Dr. Accordino on the Utility of CDK4/6 Inhibitors in HR+/HER2– Breast Cancer OncLive 1:11 4 years ago 1 384 Скачать Далее
Breaking Down Barriers to Treatment Adherence and Persistence in HR+/HER2- Early Breast Cancer PeerView Oncology 55:30 1 year ago 109 Скачать Далее
Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast Conference Total Health | Oncology 2:43 1 year ago 4 355 Скачать Далее
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer PeerView Oncology 57:18 2 years ago 2 660 Скачать Далее
ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne European Society for Medical Oncology (ESMO) 7:15 1 year ago 6 803 Скачать Далее
Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices VJOncology 2:24 1 year ago 539 Скачать Далее